A Portal-based Advance Care Planning Intervention Among Community-Dwelling Persons Living With Cognitive Impairment

NCT06509373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-02-27

No results posted yet for this study

Summary

The purpose of this research is to examine the feasibility of using a patient portal based advance care planning (ACP) tool to improve ACP discussions and documentation in persons living with cognitive impairment in outpatient primary care.

Conditions

  • Advanced Care Planning

Interventions

BEHAVIORAL

Advance Care Planning Tool - ACPVoice

Eligible patients will be sent a secure MyChart message with a motivational message asking them to complete the advance care planning tool (ACPVoice) with their care partner/surrogate decision-maker or loved one before their upcoming primary care visit. The ACPVoice tool will be attached electronically to the mychart message. A reminder message will be sent to an non-responders with a different motivational message.

BEHAVIORAL

Standard of Care for Advance Care Planning

Patients will have access to the standardized advance care planning questionnaires readily available already within their mychart account which is part of standard of care.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH
  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Jennifer Gabbard, MD · Wake Forest University Health Sciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-19
Primary Completion
2025-06-27
Completion
2025-12-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06509373 on ClinicalTrials.gov